RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marcia Cruz-Correa to Esophagogastric Junction

Back to Details
This is a "connection" page, showing publications Marcia Cruz-Correa has written about Esophagogastric Junction.
Marcia Cruz-Correa
Connection Strength
0.942
Esophagogastric Junction
  1. Cruz-Correa M, Xu RH, Moehler M, Oh DY, Kato K, Spigel D, Arkenau HT, Tabernero J, Zimina AV, Bai Y, Shi J, Lee KW, Hirano H, Wyrwicz L, Cid RP, Xu H, Sheng T, Barnes G. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction adenocarcinoma: patient-reported outcomes in the RATIONALE-305 study. Curr Med Res Opin. 2025 Jun; 41(6):1007-1016.
    View in: PubMed
    Score: 0.942
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support